Sep 2026· European Journal of Radiology· Vol 205, pp.
113214
· 0 citations· 39 references
Medicine
TL;DR
The authors' MANAS serves as a valuable complementary tool, providing longitudinal supportive evidence throughout the NAC process, from initial diagnosis to surgical intervention, and could enhance their predictive performance.
Abstract
Purpose
Neoadjuvant chemotherapy (NAC) has been established as a standard treatment for breast cancer. We aimed to develop a deep-learning multimodal system using longitudinal cross-temporal dynamic contrast-enhanced MRI (DCE-MRI) and clinical data to provide complementary evaluation of NAC.
Methods
Here, we developed a multimodal automatic NAC assistance system (MANAS), which leverages a dual-pathway attention-based multi-scale feature fusion framework and a multicenter dataset. This dataset comprises pre- and post-NAC DCE-MRI and associated clinical information of 1,515 patients with locally advanced breast cancer. The performance of MANAS was evaluated using various metrics. Confidence-based decision criteria were employed to defer low-confidence cases to clinicians.
Results
MANAS consisted of three modules from breast cancer diagnosis to follow-up treatment, designed for predicting molecular subtype, NAC response, and residual tumor burden, respectively. MANAS achieved area under the curves (AUCs) of 0.8066 (95 % CI: 0.7552-0.8599), 0.7748 (95 % CI: 0.7210-0.8275) and 0.7661 (95 % CI: 0.6980-0.8252) on the internal, pooled external and I-SPY2 test sets for molecular subtype prediction; AUCs of 0.8400 (95 % CI: 0.7903-0.8896) and 0.8299 (95 % CI: 0.7886-0.8687) on the internal and pooled external test sets for NAC response prediction; and AUCs of 0.8885 (95 % CI: 0.7891-0.9657), 0.8628 (95 % CI: 0.8047-0.9132) and 0.8695 (95 % CI: 0.7856-0.9432) on the internal, pooled external and I-SPY2 test sets for residual tumor burden prediction. Confidence-based decision criteria could enhance their predictive performance.
Conclusion
Our MANAS serves as a valuable complementary tool, providing longitudinal supportive evidence throughout the NAC process, from initial diagnosis to surgical intervention.
A novel multimodal deep learning approach that combines pre-treatment dynamic contrast-enhanced MRI and clinical data for predicting pCR before chemotherapy, and is the first to integrate attention-based multiple instance learning technique for slice aggregation and a self-supervised contrastive objective to align imag...
Manu Goyal, Tanmay Shukla, Saeed Hassanpour· Journal of imaging informati...· 0 citations
It is demonstrated that DW-MRI-based deep learning on tumor-centered patches constitutes a minimally invasive, clinically deployable strategy for early pCR prediction, with direct implications for personalized treatment adaptation in neoadjuvant breast cancer therapy.
Pablo García Marcos, M. Islam, Paula Puerta González et al.· 0 citations
BACKGROUND
Pathological complete response (pCR) is a key endpoint following neoadjuvant chemotherapy (NAC) in breast cancer, with potential to guide treatment adaptation and surgical de-escalation. However, limited generalizability across institutions remains a major challenge due to heterogeneous imaging protocols (sc...
Yong-Xi Ke, Wen-Yu Yang, Zi-Xuan Yang et al.· Translational Oncology· 0 citations
A new multi-modal machine learning framework that combines the structural, textural and functional imaging biomarkers obtained from Dynamic Contrast-Enhanced MRI for non-invasive classification of complete response (CR) and partial response (PR) shows that the combination of perfusion dynamics with radiomic descriptors...
Yasser Radouane Haddadi, Ruhul Amin Hazarika, Asaf Raza et al.· Computer Methods and Program...· 0 citations
Accurate preoperative assessment of breast lesion malignancy and axillary lymph node (ALN) status is important for individualized breast cancer management, yet current approaches are limited by diagnostic variability and invasive nodal staging. We aimed to develop and validate a multicenter artificial intelligence fr...
W. Ren, Zi-Fan He, Zhi-Xia Deng et al.· MedComm - Oncology· 0 citations
Objective To develop a multimodal predictive framework that integrates breast magnetic resonance imaging (MRI) and structured clinical features for predicting residual cancer burden (RCB) following neoadjuvant therapy. Methods The proposed Breast Cancer Multi-source Multi-scale Model (BCMM) was evaluated on the I-SPY1...
Mu-Yi Yang, Jun-Feng Hu· Frontiers in Artificial Inte...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.